A carregar...
Respiratory syncytial virus-like nanoparticle vaccination induces long-term protection without pulmonary disease by modulating cytokines and T-cells partially through alveolar macrophages
The mechanisms of protection against respiratory syncytial virus (RSV) are poorly understood. Virus-like nanoparticles expressing RSV glycoproteins (eg, a combination of fusion and glycoprotein virus-like nanoparticles [FG VLPs]) have been suggested to be a promising RSV vaccine candidate. To unders...
Na minha lista:
Publicado no: | Int J Nanomedicine |
---|---|
Main Authors: | , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4508085/ https://ncbi.nlm.nih.gov/pubmed/26203246 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S83493 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|